Vir Biotechnology Inc (VIR)

Exchange
NASDAQ
Symbol
VIR
Sector
Life Sciences
Industry
Biological Products, (no Disgnostic Substances)
Description
Vir Biotechnology, Inc., a clinical-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. The company is headquartered in San Francisco, California.
Country
USA

Stock price

At close: November 7, 2025

  • Open
    5.11
  • High
    5.16
  • Low
    4.82
  • Close
    5.13
  • Volume
    1,693,270

Financial ratios

Dec 31, 2024